Navigation Links
Solta Medical Reports Third Quarter 2009 Results
Date:11/3/2009

7,411 12,399 Customer deposits 288 288 --- --- Total current liabilities 27,995 39,059 Deferred revenue, net of current portion 526 688 Term loan, net of current portion 1,998 - Non-current tax liabilities 1,514 1,464 Other liabilities 306 133 --- --- Total liabilities 32,339 41,344 ------ ------ Stockholders' equity: Common stock, $0.001 par value: 100,000,000 shares authorized 47,866,829 and 47,758,823 shares issued and outstanding at September 30, 2009 and December 31, 2008 48 48 Additional paid-in capital 168,274 165,680 Deferred stock-based compensation - (2) Accumulated deficit (68,838) (57,902) ------- ------- Total stockholders' equity 99,484 107,824 ------ ------- Total liabilities and stockholders' equity $131,823 $149,168 ======== ========

SOURCE Solta Medical, Inc.


'/>"/>
SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
2. Solta Medical to Present at the Maxim Group Growth Conference
3. Solta Medical Launches illumiNATION tour in U.S. and Europe to Introduce New Thermage CPT(TM) and Fraxel re:store(R) Dual Systems
4. Solta Medical Launches New Fraxel re:store(R) Dual Laser System
5. Solta Medical Reports Strong Second Quarter 2009 Results
6. Solta Medical, Inc. Announces Second Quarter 2009 Results Release Date and Conference Call
7. Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank
8. Solta Medical, Inc. to Present at 8th Annual Needham Life Sciences Conference
9. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
10. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
11. Solta Medical Presents Expert Roundtable about Thermage(R) and Fraxel(R) Combination Treatments at ASLMS Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...,, KANSASCITY,Mo.,Nov.23/PRNewswire/--Christ...largestprivatelyownedinsurancebrokerage.Hoehnewill...BenefitServices practiceinLockton,s Minneapolis of...prnh/20090415/CG99351LOGO ) ,, "Wearethrilledto...fLocktonInternationalBenefitServices."Shebroadenso...
(Date:11/23/2009)..., Since 1996, crop plants genetically modified to...ain insects, yet safe for people, have been plante... popularity of these Bt crops, named after the bac...ability to kill some major pests, allowing farmers... reducing insecticide sprays. , However, since i...
(Date:11/23/2009)... Study found one more than doubled chances, while ..., Nov. 23 (HealthDay News) -- Children whose mothe...lead have more than double the risk of having atte...er children, new research shows. , And with exp...having ADHD soared. Children whose mothers smoked ...
(Date:11/23/2009)...,, DALLAS,Nov.23/PRNewswire/--TheBerylCompan...erservicesforthehealthcareindustry,hasearnedrecogn...odernHealthcare ,theindustry,sleadingtrademagazine...ngfirmsbasedonBeryl,s2008businessresults,whichenab..., Berylattributesthisgrowthtoitsinnovativeproduc...
(Date:11/23/2009)..., Information about Oxyco...y launched DopeStats.com. The new site is a statis...d use rates of Oxycodone in each county in the Uni...le who have used the drug for recreational or medi... FL (PRWEB) November 23, 2009 -- Legal and illegal...
Breaking Medicine News(10 mins):Health News:Lockton Benefit Group Expands International Benefit Team 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2Health News:DopeStats.com Provides Statistics on Oxycodone Abused in Non-Medical Purposes 2
...an biotech major Biocon Ltd has roped in Bayer Hea...sugen in the Chinese market, the company //said in...biotech firm plans to launch Insugen in China by 2... countries in the Asia-Pacific region later. The i...
...sh Sindhi, a surgeon and a researcher at the child...how the new low dose anti rejection protocol //has...al transplant recipients. Research performed b...s drug doses and eliminates steroids altogether in...
...Baldomero Olivera said that the ruthless fish-eati...c back pain.// He is planning to present his f...one snails, with their striking patterns and elega...aturday and Sunday, October 7-8, 10 a.m.-5 p.m. at...
...rding to the study conducted by the Queen's Univer... how genes work to protect the aortic muscle new t...ts suffering from arteriosclerosis. It is one ...-1 (HO-1) markedly protects the arteriosclerois-pr...
...rding to the scientist from the Victorian Breast C...east stem cells which have undergone some mutation...ancers.// The Walter and Eliza Hall Institute ...esterone. This characteristic is very similar to t...
...rding to a new research conducted at the Universit...nd that increased serotonin aids to curb appetite.... stimulated by various drugs such Fen-phen and oth...ffects. The study, which tested the effect of seve...
Other Medicine News:Health News:Bayer to Market Biocon Insulin in China 2Health News:Low Dose Anti Rejection Protocol Helps Intestinal Transplant Recipients 2Health News:Genes Identified To Protect Heart Muscles 2Health News:Mutation in Breast Stem Cells Lead to Breast Cancer 2Health News:Serotonin the Answer for Anti-Obesity Treatment 2
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 An...infectious diseases in the developing world has pr...ademic researchers, non-profit product development...chnology companies. As noted today in a symposium ... of Tropical Medicine and Hygiene (ASTMH), these c...
(Date:11/20/2009)... , , BOSTON, Nov. 20 Th...rcuit upheld an earlier District Court ruling yest...Average Wholesale Price (AWP) pharmaceutical litig...,, (Logo: http://www.newscom.com/cgi-bin/prnh/...ettlement that awarded consumers who purchased the...
(Date:11/20/2009)... , , CARY, N.C., Nov. 20 /PRNewswire-Firs...CRTX ), a specialty pharmaceutical company focused...ificant products primarily for the respiratory and...ved a Warning Letter from the Food and Drug Admini...wable tablets (Phenylephrine HCl 10 mg, Pyrilamine...
Breaking Medicine Technology:ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Weight Loss Surgery Simplified 47681 1Weight Loss Surgery Simplified 47681 2Updegraff Vision Launches Educational Blog Podcast Site for LASIK and Cataract Patients 47677 1Updegraff Vision Launches Educational Blog Podcast Site for LASIK and Cataract Patients 47677 2Dow AgroSciences World Wide Wheat Agree to Collaborate on Wheat 4520 1Dow AgroSciences World Wide Wheat Agree to Collaborate on Wheat 4520 2
...ell engaging antibody (BiTE) showing clinical bene...nts own T cells to recognize and attack ...ug. 14 Micromet, Inc.,(Nasdaq: MITI ), a biophar...ntibodies for the treatment of cancer, inflammatio...tion of a Phase 1 clinical study(1) on its,BiTE(R)...
...Aug. 13 As biotechnology,pharmaceutical and medic...als beyond their own borders to other parts of the...ica, complicated regulatory environments,challenge... an analysis by,Aon Corporation (NYSE: AOC ). Aon...mpanies a visual representation of the complex ins...
Other Medicine Technology:Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4
Montana2
...eveloped to further protect the ACL and enhance th...ed Fource Point hinges are designed to react durin... in the last 35 degrees of extension, in order to ...al loads. The hinge has three adjustment settings ...
Tri-Panel Knee Immobilizer
...race uses muscle power to place a laterally (Align...inst the knee during terminal extension to help re...l or medial compartment arthrosis. For moderate to...,Indications,Aligner LA - This device is indicate...
Medicine Products: